World-first clinical trial demonstrates focused ultrasound can deliver antibody therapy to breast cancer metastases in the brain
Researchers at Sunnybrook Health Sciences Centre have successfully delivered antibody therapy to breast cancer metastases in the brain using focused ultrasound. The treatment, which temporarily opens the blood-brain barrier, has shown promising results with tumor size reductions of up to 21% in patients.
SourceFocused Ultrasound Foundation·JournalScience Translational Medicine·TypeRandomized controlled/clinical trial·DateOct 13, 2021